Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03500668
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NBD | N6-BENZYL-NICOTINAMIDE-ADENINE- DINUCLEOTIDE | A,B,C,D | 1GYQ | 0.72 | |
FR9 | 1-[(1R)-3-(6-{[(BENZYLAMINO)CARBONYL]AMINO}- 1H-INDOL-1-YL)-1-(HYDROXYMETHYL)PROPYL]- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1O5R | 0.7 | |
AGN | A | 1GNP | 0.7 | ||
DZD | 5'-O-[(R)-{[(R)-{[(3R,4R)-1-(3- carbamoylbenzyl)-4-hydroxypyrrolidin- 3-yl]methoxy}(hydroxy)phosphoryl]methyl}(hydroxy)phosphoryl]adenosine | A,D | 3D4B | 0.71 | |
DAK | 4-(N,N-DIMETHYLAMINO)CINNAMOYL- COA | A,B,C,D,E,F | 1EY3 | 0.71 | |
SFC | (S)-IBUPROFENOYL-COENZYME A | A,B,C,D | 2GCE | 0.7 | |
FR6 | 1-{(1R,2S)-2-HYDROXY-1-[2-(1-NAPHTHYL)ETHYL]PROPYL}- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 2E1W | 0.7 | |
RFC | (R)-IBUPROFENOYL-COENZYME A | A,B,C,D | 2GCE | 0.7 | |
ABR | (R)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5E | 0.72 | |
8FG | N-(5'-PHOSPHO-2'-DEOXYGUANOSIN- 8-YL)-2-ACETYLAMINOFLUORENE | A,C,D | 1X9M | 0.76 | |
GSR | A | 1AF1 | 0.82 | ||
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1TL7 | 0.73 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1U0H | 0.73 | |
N2G | A,P,T | 2W8K | 0.77 | ||
N2G | A,P,T | 2W8L | 0.77 | ||
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 2ALY | 0.71 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 1VBM | 0.71 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 1VBN | 0.71 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 2PID | 0.71 | |
FTB | N-{4-[1-(2-FLUOROBENZYL)-3-BUTYL- 2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H- PURIN-8-YLMETHYL]-PHENYL}-ACETAMIDE | A | 1NHX | 0.72 | |
FAE | FLAVIN-N7 PROTONATED-ADENINE DINUCLEOTIDE | A | 3B3R | 0.71 | |
FAE | FLAVIN-N7 PROTONATED-ADENINE DINUCLEOTIDE | A | 1MXT | 0.71 | |
FAE | FLAVIN-N7 PROTONATED-ADENINE DINUCLEOTIDE | A | 1N4U | 0.71 | |
FAE | FLAVIN-N7 PROTONATED-ADENINE DINUCLEOTIDE | A | 3B6D | 0.71 | |
V12 | 5'-[(1H-BENZIMIDAZOL-2-YLACETYL)AMINO]- 5'-DEOXYCYTIDINE | A,B | 2V2V | 0.8 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A | 2BGM | 0.72 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1N8K | 0.72 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A | 2BGL | 0.72 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1N92 | 0.72 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1H2B | 0.72 | |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A,B | 2IY5 | 0.74 | |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A | 1B7Y | 0.74 | |
PUY | PUROMYCIN | A,B | 2DPT | 0.72 | |
PUY | PUROMYCIN | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q7Y | 0.72 | |
3BK | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4- dichlorophenyl)methylamino]purin- 9-yl]-5-(hydroxymethyl)oxolane- 3,4-diol | A | 3FZK | 0.72 | |
NBS | A | 1KSW | 0.75 | ||
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CET | 0.74 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CER | 0.74 | |
CF2 | 2'-deoxy-5'-O-{[2-(7,8-dimethyl- 2,4-dioxo-3,4-dihydrobenzo[g]pteridin- 10(2H)-yl)ethyl]carbamoyl}guanosine | A | 2VKF | 0.75 | |
FR2 | 1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDW | 0.73 | |
GSZ | N-[(5R,6R,7R,8S)-6,7-DIHYDROXY- 5-(HYDROXYMETHYL)-2-(2-PHENYLETHYL)- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDIN-8-YL]-2-METHYLPROPANAMIDE | A,B | 2J62 | 0.76 | |
DBG | 3-AMINOBENZOPHENONE-4-YL-AMINOHYDROXYPHOSPHINYLAMINOPHOSPHONIC ACID- GUANYLATE ESTER | A | 1RVD | 0.73 | |
DBG | 3-AMINOBENZOPHENONE-4-YL-AMINOHYDROXYPHOSPHINYLAMINOPHOSPHONIC ACID- GUANYLATE ESTER | A | 1CLU | 0.73 | |
FAO | A,B | 2JBV | 0.71 | ||
LIR | 2-[(3S)-3-AMINOPIPERIDIN-1-YL]- 1-(2-CYANOBENZYL)-5-METHYL-4,6- DIOXO-3,4,5,6-TETRAHYDROPYRROLO[3,4- D]IMIDAZOL-1-IUM | A | 2I3Z | 0.71 | |
NVG | 4-AMINO-1-(5-{[3-(1H-BENZIMIDAZOL- 2-YL)PROPANOYL]AMINO}-5-DEOXY-ALPHA- L-LYXOFURANOSYL)PYRIMIDIN-2(1H)- ONE | A,B | 2V2Q | 0.79 | |
RUN | 2-[(1R,3S,4S)-1-BENZYL-4-[N-(BENZYLOXYCARBONYL)- L-VALYL]AMINO-3-PHENYLPENTYL]-4(5)- (2-METHYLPROPIONYL)IMIDAZOLE | B | 1HPS | 0.72 | |
6HI | (3R,5R)-7-{2-[(4-fluorobenzyl)carbamoyl]- 4-(4-fluorophenyl)-1-(1-methylethyl)- 1H-imidazol-5-yl}-3,5-dihydroxyheptanoic acid | B,C,D | 3CD0 | 0.73 | |
MGQ | 7-BENZYL GUANINE MONOPHOSPHATE | A,E | 2V8X | 0.83 | |
MGV | P-FLUORO-7-BENZYL GUANINE MONOPHOSPHATE | A,E | 2V8Y | 0.81 | |
MS1 | A,B | 1OZ0 | 0.72 | ||
TSX | N-[4-(1-ALLYL-3-BUTYL-2,6-DIOXO- 2,3,6,7-TETRAHYDRO-1H-PURIN-8-YLMETHYL)- PHENYL]-ACETAMIDE | A | 1M51 | 0.75 | |
IMK | 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL- 1-BENZIMIDAZOLE | A | 1XKX | 0.78 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1X38 | 0.71 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1LQ2 | 0.71 | |
ABS | (S)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5F | 0.72 | |
VGB | (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)- 2-(2-phenylethyl)-8-(propanoylamino)- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2WB5 | 0.77 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A | 1X39 | 0.71 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A,B | 2J7C | 0.71 | |
G37 | 2-(BENZYLCARBAMOYL-PHENYLACETYLAMINO- METHYL)-5,5-DIMETHYL-THIAZOLIDINE- 4-CARBOXYLIC ACID 3-[(1H-BENZIMIDAZOL- 2-YLMETHYLCARBAMOYL)-1-BENZYL-2- HYDROXYPROPYL]-AMIDE | A | 1HTG | 0.7 | |
GSS | A | 1AP1 | 0.82 | ||
WSA | 5'-O-[(L-TRYPTOPHYLAMINO)SULFONYL]ADENOSINE | A,B,C,D | 2YY5 | 0.72 | |
NGD | A,B | 2O3U | 0.72 | ||
ONA | A,C | 2GVZ | 0.7 | ||
CAG | A | 1GNQ | 0.74 | ||
CAG | A | 1PLJ | 0.74 | ||
CAG | X | 2EVW | 0.74 | ||
CAG | A | 1GNR | 0.74 | ||
CAG | X | 2CL6 | 0.74 | ||
4HI | (3R,5R)-7-[4-(benzylcarbamoyl)- 2-(4-fluorophenyl)-5-(1-methylethyl)- 1H-imidazol-1-yl]-3,5-dihydroxyheptanoic acid | B,C,D | 3CCW | 0.76 | |
BPG | 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE | A,B | 1QHI | 0.71 | |
FA5 | ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE] | A | 3CMQ | 0.73 | |
FA5 | ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE] | A,B | 1JJC | 0.73 | |
FSH | A | 3D2H | 0.7 | ||
G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | A,B | 3GRJ | 0.73 | |
NHV | (5R,6R,7S,8R)-6,7,8-trihydroxy- 5-(hydroxymethyl)-2-[(phenylamino)methyl]- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2VOT | 0.73 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 1SZC | 0.71 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A | 1A26 | 0.71 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 2OD2 | 0.71 | |
GDV | (5R,6R,7R,8S)-8-(ACETYLAMINO)-6,7- DIHYDROXY-5-(HYDROXYMETHYL)-N-PHENYL- 1,5,6,7,8,8A-HEXAHYDROIMIDAZO[1,2- A]PYRIDINE-2-CARBOXAMIDE | A | 2J47 | 0.8 | |
SC3 | 7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN- 1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE | A,B,C,D | 2AJ8 | 0.73 | |
5HI | (3R,5R)-7-[2-(4-fluorophenyl)-4- {[(1S)-2-hydroxy-1-phenylethyl]carbamoyl}- 5-(1-methylethyl)-1H-imidazol-1- yl]-3,5-dihydroxyheptanoic acid | A,B,C,D | 3CCZ | 0.76 | |
UA2 | 3,4-PYRROLIDINEDIOL,2-(4-AMINO- 5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)- 5-(HYDROXYMETHYL)-2S,3S,4R,5R | A,B,C | 2I4T | 0.7 |